The news could be updated on; >> IHL-42X Commencement of Clinical Phase 2/ 3 Blended Trials in USA >> PSI-GAD Completion of PSI-GAD Phase 2 at Monash & commencement of Data Compilation and or >> PSI-GAD Filing of an IND with the FDA for a blended Phase 2/3 Trial
>> Update on progress of IHL-675A (R/A) Phase 2 Trials in AUS >> Snippets of newsflow concerning the progress of approvals for Clarion Clinic - Melbourne for PTSD & TRD. >> Chewies Update >> Re-domicile Update
1st Court Hearing Compl?
Shareholder booklet mail-out?
>> USA Executive Trip Updates
New USA Registry Agreement nailed down?
Bob & George catchups?
Fortrea catchup (CRO for IHL-42X USA Trials)
Appointment of Pipeline / Regulatory Affairs Manager (Vice-President !!) based in the USA to promote Pipelines / Licensing / Partnerships.
Will try to keep updated as we progress to the Shareholder Vote and outcome.
GLAH Remember, keep those emails from Joel updated here thanks to those posters!
IHL Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held